Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
9.12
+0.04 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
8.96
-0.16 (-1.75%)
After-hours: Mar 9, 2026, 7:57 PM EDT
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $316.89 million as of March 9, 2026. Its market cap has decreased by -33.40% in one year.
Market Cap
316.89M
Enterprise Value
226.79M
1-Year Change
-33.40%
Ranking
Category
Stock Price
$9.12
Market Cap Chart
Since May 1, 2020, Delcath Systems's market cap has increased from $11.70M to $316.89M, an increase of 2,608.42%. That is a compound annual growth rate of 75.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 316.90M | -11.16% |
| Dec 31, 2025 | 356.70M | -7.35% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 530.77% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 419.78M |
| Standard BioTools | 379.10M |
| Cerus | 370.89M |
| Viemed Healthcare | 358.62M |
| ClearPoint Neuro | 343.30M |
| RxSight | 312.39M |
| TriSalus Life Sciences | 285.07M |
| Senseonics Holdings | 263.57M |